No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease

Journal of Neurochemistry

Volumn 75, Issue 2, 2000, Pages 840-846

  Alam, Zafar I ^a   Halliwell, Barry ^a,b   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

DNA; Huntington's disease; Lipids; Oxidative damage; Proteins

Indexed keywords

8 HYDROXYGUANINE; LIPID; LIPID PEROXIDE; M PROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID;

ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DNA DAMAGE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; LIPID PEROXIDATION; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PUTAMEN;

ADULT; AGED; BRAIN; CAUDATE NUCLEUS; DNA; FEMALE; FRONTAL LOBE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HUNTINGTON DISEASE; LIPID METABOLISM; MALE; MALONDIALDEHYDE; MIDDLE AGED; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PUTAMEN; REFERENCE VALUES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0033914874     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750840.x     Document Type: Article

References (34)

1. Alam Z. I., Daniel S. E., Lees A. J., Marsden C. D., Jenner P., and Halliwell B. (1997a) A generalised increase in oxidative protein damage in the brain in Parkinson's disease. J. Neurochem. 69, 1326-1329.
2. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P., and Halliwell B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196-1203.
3. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M. K., Bird E. D., and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease. Selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
4. Browne S. E., Ferrante R. J., and Beal M. F. (1999) Oxidative stress in Huntington's disease. Brain Pathol. 9, 147-163.
5. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
6. Drukarch B., Schepens E., Stoof J. C., Langveld C. H., and Van Muiswinkel F. L. (1998) Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species. Free Radic. Biol. Med. 25, 217-220.
7. Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey E., and Beal M. F. (1993) Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterisation. Exp. Neurol. 119, 46-71.
8. Fiskum G., Murphy A. N., and Beal M. F. (1999) Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab. 19, 351-369.
9. Greene J. G., Porter R. H. P., Eller R. V., and Greenamyre J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 61, 1151-1154.
10. Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M., and Schapira A. H. V. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 386-389.
11. Halliwell B. (1998) Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Free Radic. Res. 29, 469-486.
12. Halliwell B. and Gutteridge J. M. C. (1999) Free Radicals in Biology and Medicine, 3rd edit., pp. 721-761. Oxford University Press, Oxford.
13. Halliwell B., Cross C. E., and Gutteridge J. M. C. (1992) Free radicals, antioxidants and human disease. Where are we now? J. Lab. Clin. Med. 119, 598-620.
14. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
15. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
16. Jenner P. and Olanow C. W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44 (Suppl. 1), S72-S84.
17. LeVine S. M. and Wetzel D. I. (1998) Chemical analysis of multiple sclerosis lesions by FT-IT microspectroscopy. Free Radic. Biol. Med. 25, 33-41.
18. Li X.-J., Li S.-H., Sharp A. H., Nucifora F. C. Jr., Schilling G., Lanahan G., Worley P., Snyder S. H., and Ross C. A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
19. Lyras L., Evans P. J., Shaw P. J., Ince P. G., and Halliwell B. (1996) Oxidative damage and motor neurone disease. Difficulties in the measurement of protein carbonyls in human brain tissue. Free Radic. Res. 24, 397-406.
20. Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
21. Lyras L., Perry R. H., Perry E. K., Ince P. G., Jenner A., Jenner P., and Halliwell B. (1998) Oxidative damage to proteins, lipids and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71, 302-312.
22. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
23. Martindale D., Hackam A., Wieczorek A., Ellerby L., Wellington C., McCutcheon K., Singaraja R., Kazemi-Esfarjani P., Devon R., Kim S. U., Bredesen D. E., Tufaro F., and Hayden M. R. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet. 18, 150-154.
24. Mecocci P., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
25. Palfi S., Ferrante R. J., Brouillet E., Beal M. F., Dolan R., Guyot M. C., Peschanski M., and Hantraye P. (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16, 3019-3025.
26. Palmer A. M. and Burns M. A. (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645, 338-342.
27. Papadopoulos M. C., Koumenis I. L., Xu L., and Giffard R. G. (1998) Potentiation of murine astrocyte antioxidant defence by bcl-2: protection in part reflects elevated glutathione levels. Eur. J. Neurosci. 10, 1252-1260.
28. Polidori M. C., Mecocci P., Browne S. E., Senin U., and Seal M. F. (1999) Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neurosci. Lett. 272, 53-56.
29. Sanchez-Ramos J., Overvik E., and Ames B. N. (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigrostriatum of Parkinson's disease brain. Neurodegeneration 3, 197-204.
30. Senturker A. and Dizdaroglu M. (1999) The effects of experimental conditions on the levels of oxidatively modified bases in DNA as measured by gas chromatography-mass spectrometry. Free Radic. Biol. Med. 27, 370-380.
31. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
32. Smith M. A., Sayre L. M., Anderson V. E., Beal M. F., Kowall N., Richey P. L., and Perry G. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
33. Spencer J. P. E., Jenner A., Aruoma O. I., Cross C. E., Wu R., and Halliwell B. (1996) Oxidative DNA damage in human respiratory tract cell epithelial cells. Time-course in relation to DNA strand breakage. Biochem. Biophys. Res. Commun. 224, 17-22.
34. Tabrizi S. J., Workman J., Hart P. E., Mangiarini L., Mahal A., Bates G., Cooper J. M., and Schapira A. H. V. (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann. Neurol. 47, 80-86.